1.25 g/5 ml
Trade Name
Amiroic
Oral Solution
Request Type
Registration
Drug Type
Generic Drug
Approval Date
SFDA Approved Use
Aminocaproic acid is indicated for use in patients of all ages in haemorrhage caused by local or general fibrinolysis, including in Postsurgical haemorrhages in:
•Urology (surgery of the bladder and prostate)
•Gynaecology (cervical surgery), in patients where tranexamic acid is not available or not tolerated
•Obstetrics (post-partum and post-miscarriage haemorrhages) after correction of the coagulation defect
•Heart surgery (with or without bypass placement)
•Gastroenterology
•Odonto-stomatology (dental extractions in haemophiliacs, patients undergoing anticoagulanttherapy) Life-threatening haemorrhages induced by thrombolytics (streptokinase, etc.). Haemorrhages associated with thrombocytopenia, thrombopenic purpura, leukaemia. Nonsurgical haematuria of the lower urinary tract (secondary to cystitis, etc.). Intense menstruations, menorrhagia and haemorrhagic metropathies. Angioneurotic oedema.
•Urology (surgery of the bladder and prostate)
•Gynaecology (cervical surgery), in patients where tranexamic acid is not available or not tolerated
•Obstetrics (post-partum and post-miscarriage haemorrhages) after correction of the coagulation defect
•Heart surgery (with or without bypass placement)
•Gastroenterology
•Odonto-stomatology (dental extractions in haemophiliacs, patients undergoing anticoagulanttherapy) Life-threatening haemorrhages induced by thrombolytics (streptokinase, etc.). Haemorrhages associated with thrombocytopenia, thrombopenic purpura, leukaemia. Nonsurgical haematuria of the lower urinary tract (secondary to cystitis, etc.). Intense menstruations, menorrhagia and haemorrhagic metropathies. Angioneurotic oedema.